OCULIS
Summary
Oculis is a late-stage biopharmaceutical company focused on developing transformative ophthalmic treatments to improve the sight and lives of patients.
Deals Overview
Total Deals2
Valued Deals2
Total Value£ 235 M
Avg. Deal Size£ 118 M
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite
